The treatment options for prostate cancer (PC) care include surgery, radiotherapy, and chemotherapy. However, surgery and radiotherapy are effective when the tumor is localized and detected during the early stages [1]. On the other hand, chemotherapy, while effective during the early-stage tumor development, often induces side effects. These treatment strategies are ineffective once the tumor has metastasized from the prostate to other parts of the human body. Most PC deaths may be due to metastases that are highly resistant to the treatment options [2]. Even when treated, PC usually returns in the first few years after treatment.